Earlier quoted context omitted.
Vaccines are interesting, but I'm much more intrigued by what this may mean for future therapeutics if their methods work well moving forward.
There are a lot of companies (including mine) that have been working on personalised, target, combinatorial, interfering, etc. RNA therapeutics for quite some time. The success of RNA vaccines in the last year has really opened up the potential for pharma partnerships to test and develop these kinds of things. They have built out the infrastructure and there's a broad confidence and awareness of the basic concepts th…
Astrazeneca is working together with Moderna on respiratory diseases, which is interesting for me, as I have asthma.